Highlights

  • Zycov D likely to be available from October
  • Deemed safe for children above 12 years of age
  • 3 doses with 28 day intervals recommended

Latest news

Pahalgam tragedy casts shadow on Indo-Pak cricket

Pahalgam tragedy casts shadow on Indo-Pak cricket

MS Dhoni to play his 400th T20 match as CSK faces SRH

MS Dhoni to play his 400th T20 match as CSK faces SRH

India stands tall amid tragedy: Piyush Goyal

India stands tall amid tragedy: Piyush Goyal

ED raids Congress MLA Vinay Kulkarni's properties

ED raids Congress MLA Vinay Kulkarni's properties

VHP stages protest in Kolkata over Pahalgam attack

VHP stages protest in Kolkata over Pahalgam attack

Kartarpur corridor stays open amid tensions

Kartarpur corridor stays open amid tensions

Hero and terrorist: The tale of two Adils in Pahalgam

Hero and terrorist: The tale of two Adils in Pahalgam

Pahalgam survivor recalls horror, wife prays Shiva

Pahalgam survivor recalls horror, wife prays Shiva

Meet ZyCoV-D: The world’s first DNA Covid-19 vaccine; everything you need to know about the new vaccine

The shot is “the world’s first and India’s indigenously developed DNA-based vaccine for Covid-19 to be administered in humans including children and adults 12 years and above.”

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Zydus Cadila's covid vaccine ZyCoV-D is set to be launched in India in October and is deemed for safe for kids above 12. This 'third-generation triple dose vaccine' could just be the answer to fill the gap of 100 crore doses required by year-end to vaccinate the vast majority of the adult population. Here is everything you need to know about this non-injecting, DNA vaccine which even children above 12 can take.

      Meet Cadila’s ZyCoV-D

      • It is the world’s first DNA vaccine to protect against Covid 19. Requires a triple dose for immunity and showcased 67% efficacy in trials. The vaccine is deemed safe for children above the age of 12.

      What kind of vaccine is it? How is it different than Covishield and Covaxin?

      • Cadila’s ZyCoV-D is a plasmid DNA vaccine that introduces a DNA sequence encoding the antigen in the body and not a weakened form of the pathogen like Covaxin.

      How does a DNA vaccine work?

      • Often referred to as the third-generation vaccines, the dose carries the genetic code of the virus that triggers the build up of immunity in one's body.
      • Zydus stated that the plasmid DNA platform is “ideally suited for dealing with Covid-19 as it can be easily adapted to deal with mutations in the virus, such as those already occurring”.

      Is a DNA vaccine being used anywhere else in the world?

      • No DNA vaccine has been widely used against any disease so far, but they are more stable and easier to store than mRNA shots (tech used by Pfizer & Moderna)
      • According to the U.S. National Library of Medicine, over 160 different DNA vaccines are currently being tested in human clinical trials in the United States. It is estimated that 62% of these trials are devoted to cancer vaccines and 33% are applied for vaccines against human immunodeficiency virus (HIV).

      How many doses does one need?

      • Unlike most other Covid-19 vaccines, which require two doses for full immunity, ZyCoV-D is administered in three doses. The vaccine is also needle-free.
      • The doses will be administered 28 days apart

      Needle-free vaccine, how does one get the dose?

      • Doses are given using a device that delivers fluid through a spring-powered jet that penetrates the skin, developed by Pharmajet’s Tropis.
      • Zydus Cadila claims this method of delivery is painless and could also reduce side effects from the jab

      Is it safe? What are the trial results showing?

      • The vaccine has been tested on almost 30,000 participants across Phase I, II and III studies, and is the first vaccine in India to be tested on 12 to 18-year-olds. Around 1,000 participants were enrolled in the adolescent age group, among whom the vaccine was found to be safe and well-tolerated, with similar findings in the adult population

      Sushmita Sen

      ADVERTISEMENT

      Up Next

      Meet ZyCoV-D: The world’s first DNA Covid-19 vaccine; everything you need to know about the new vaccine

      Meet ZyCoV-D: The world’s first DNA Covid-19 vaccine; everything you need to know about the new vaccine

      Global stock market indices: How the world markets performed today - 25 April 2025

      Global stock market indices: How the world markets performed today - 25 April 2025

      Indian stock market sector-wise performance today - April 25 2025

      Indian stock market sector-wise performance today - April 25 2025

      Top 5 Nifty 50 gainers today – April 25, 2025: Biggest stock moves

      Top 5 Nifty 50 gainers today – April 25, 2025: Biggest stock moves

      NSE Nifty 50: Top 5 stock losers of April 25, 2025

      NSE Nifty 50: Top 5 stock losers of April 25, 2025

      Global stock market indices: How the world markets performed today - 24 April 2025

      Global stock market indices: How the world markets performed today - 24 April 2025

      ADVERTISEMENT

      editorji-whatsApp

      More videos

      Indian stock market sector-wise performance today - April 24 2025

      Indian stock market sector-wise performance today - April 24 2025

      Top 5 Nifty 50 gainers today – April 24, 2025: Biggest stock moves

      Top 5 Nifty 50 gainers today – April 24, 2025: Biggest stock moves

      NSE Nifty 50: Top 5 stock losers of April 24, 2025

      NSE Nifty 50: Top 5 stock losers of April 24, 2025

      Global stock market indices: How the world markets performed today - 23 April 2025

      Global stock market indices: How the world markets performed today - 23 April 2025

      Indian stock market sector-wise performance today - April 23, 2025

      Indian stock market sector-wise performance today - April 23, 2025

      Top 5 Nifty 50 gainers today – April 23, 2025: Biggest stock moves

      Top 5 Nifty 50 gainers today – April 23, 2025: Biggest stock moves

      NSE Nifty 50: Top 5 stock losers of April 23, 2025

      NSE Nifty 50: Top 5 stock losers of April 23, 2025

      Sensex, Nifty rise for 6th day on foreign fund inflows, buying in banking shares

      Sensex, Nifty rise for 6th day on foreign fund inflows, buying in banking shares

      Global stock market indices: How the world markets performed today - 22 April 2025

      Global stock market indices: How the world markets performed today - 22 April 2025

      Indian stock market sector-wise performance today - April 22, 2025

      Indian stock market sector-wise performance today - April 22, 2025

      Editorji Technologies Pvt. Ltd. © 2022 All Rights Reserved.